Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Chamow

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Molecular Immunology|December 1, 1994
Molecular and biological properties of an interleukin-1 receptor immunoadhesinR M Pitti, S A Marsters, M Haak-Frendscho, et al.
Progress in Clinical and Biological Research|January 1, 1989
Developmental expression of ZP3, a mouse zona pellucida geneJ Dean, M E Chamberlin, S E Millar, et al.
Journal of Virology|October 1, 1989
Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4R A Byrn, I Sekigawa, S M Chamow, et al.
Bioconjugate Chemistry|March 1, 1994
Modification of CD4 immunoadhesin with monomethoxypoly(ethylene glycol) aldehyde via reductive alkylationS M Chamow, T P Kogan, M Venuti, et al.
Biochemistry|October 23, 1990
Enzymatic cleavage of a CD4 immunoadhesin generates crystallizable, biologically active Fd-like fragmentsS M Chamow, D H Peers, R A Byrn, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1991
Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesinA Ashkenazi, S A Marsters, D J Capon, et al.
Journal of Hematotherapy|October 1, 1995
A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cellsS M Chamow, D Zhang, X Y Tan, et al.
Nature|February 9, 1989
Designing CD4 immunoadhesins for AIDS therapyD J Capon, S M Chamow, J Mordenti, et al.
The Journal of Biological Chemistry|July 14, 1995
Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activityT F Zioncheck, L Richardson, J Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1994
A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cellsS M Chamow, D Z Zhang, X Y Tan, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Molecular Immunology|December 1, 1994
Molecular and biological properties of an interleukin-1 receptor immunoadhesinR M Pitti, S A Marsters, M Haak-Frendscho, et al.
Progress in Clinical and Biological Research|January 1, 1989
Developmental expression of ZP3, a mouse zona pellucida geneJ Dean, M E Chamberlin, S E Millar, et al.
Journal of Virology|October 1, 1989
Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4R A Byrn, I Sekigawa, S M Chamow, et al.
Bioconjugate Chemistry|March 1, 1994
Modification of CD4 immunoadhesin with monomethoxypoly(ethylene glycol) aldehyde via reductive alkylationS M Chamow, T P Kogan, M Venuti, et al.
Biochemistry|October 23, 1990
Enzymatic cleavage of a CD4 immunoadhesin generates crystallizable, biologically active Fd-like fragmentsS M Chamow, D H Peers, R A Byrn, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1991
Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesinA Ashkenazi, S A Marsters, D J Capon, et al.
Journal of Hematotherapy|October 1, 1995
A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cellsS M Chamow, D Zhang, X Y Tan, et al.
Nature|February 9, 1989
Designing CD4 immunoadhesins for AIDS therapyD J Capon, S M Chamow, J Mordenti, et al.
The Journal of Biological Chemistry|July 14, 1995
Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activityT F Zioncheck, L Richardson, J Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1994
A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cellsS M Chamow, D Z Zhang, X Y Tan, et al.
Pageof 4